Four Sponsors Commit $100,000 to Launch Medicinal Hazard Data Standardization Consortium

ACCESS Newswire···Read original
1▲1 ▼0Impact / 5
Summary · why it matters

Four industry sponsors have committed $100,000 to launch the Medicinal Hazard Data Standardization Consortium, a nonprofit global collaboration developing standardized Medicinal Hazard Data Sheets. The funding from Pharmacy Stars, BD, EQUASHIELD, and EuroBioConcept addresses the fragmented hazardous drug classification across NIOSH, USP <800>, ISOPP, and European directives, which leaves hospitals and pharmacies to independently assess toxicological risks. The consortium will maintain an open, consensus-governed framework to identify and communicate hazards across the drug lifecycle, with outputs free from commercial influence. The announcement coincides with the 84th FIP World Congress in Montréal, where a presentation on an internationally harmonized hazardous drug list will be given on September 1.

Impact on assets 1

Biotech & Genomic Medicine▲
Becton Dickinson and Company
BDX
▲ PositiveCapitalrelevance

BD is one of four sponsors committing $100,000 to launch the Medicinal Hazard Data Standardization Consortium.

Off-coverage companies 3

Equashieldi
Private▲ PositiveCapitalrelevance

EQUASHIELD is one of four sponsors committing $100,000 to launch the Medicinal Hazard Data Standardization Consortium.

EuroBioConcepti
Private▲ PositiveCapitalrelevance

EuroBioConcept is one of four sponsors committing $100,000 to launch the Medicinal Hazard Data Standardization Consortium.

Pharmacy Starsi
Private▲ PositiveCapitalrelevance

Pharmacy Stars is one of four sponsors committing $100,000 to launch the Medicinal Hazard Data Standardization Consortium.